Skip to main content

Moleculin Biotech, Inc 8-K, filed Nov 18, 2026

Moleculin Biotech, Inc. (MBRX)

8-K 2026-11-18 For: 2026-11-18
View Original
Added on November 18, 2026

About this 8-K

Moleculin Biotech, Inc filed this 8-K on November 18, 2026.

South Korea's Ministry of Intellectual Property has issued a decision to grant a patent covering the method of reconstituting liposomal Annamycin, adding another major market to its patent estate spanning more than 20 jurisdictions. AI summary

Items reported

  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits